Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...

A MUM has shared a shocking photo of a giant lump protruding from her breast, which doctors repeatedly dismissed a benign.

The researchers found that imlunestrant prolonged progression-free survival (PFS) when compared to standard care in patients with ESR1 mutations, but there was no PFS benefit observed in the overall ...

The FDA approved trastuzumab deruxtecan for adult patients with unresectable or metastatic HER2-low or HER2-ultralow breast ...

Extensive research shows that drinking alcohol increases the risk of cancer, and U.S. public-health authorities are following the example of other countries in increasing public awareness about ...

Beloved TV host Ananda Lewis shares her story and a message to Black women about prioritizing their health in the new year.

Datopotamab deruxtecan-dlnk significantly improves progression-free survival in HR-positive, HER2-negative breast cancer compared with chemotherapy. The TROPION-Breast01 trial showed a higher ...

As supported by data from the phase 3 TROPION-Breast01 trial, datopotamab deruxtecan is now an FDA-approved treatment for patients with HR-positive, HER2-negative breast cancer. The FDA has approved ...

Maureen Nolan has revealed that her sister Linda Nolan's death was not directly caused by cancer, but rather by ... "I try to stay positive." In 2023, she spoke to The Mirror saying, "I think ...

A new Federal Trade Commission (FTC) report found that the three largest Pharmacy Benefit Managers (PBMs) have taken in large profits on lifesaving medicine for heart disease, cancer and HIV.